Thromb Haemost 1994; 71(03): 363-365
DOI: 10.1055/s-0038-1642444
Original Article
Schattauer GmbH Stuttgart

Effect of Low Molecular Weight Heparin, Dextran and Their Combinations on Experimental Venous Thrombosis in Rabbits

Stefan E Matthiasson
The Departments of Surgery and Experimental Research, Lund University, Malmö General Hospital, Malmö, Sweden
,
Bengt Lindblad
The Departments of Surgery and Experimental Research, Lund University, Malmö General Hospital, Malmö, Sweden
,
Thomas Mätzsch
The Departments of Surgery and Experimental Research, Lund University, Malmö General Hospital, Malmö, Sweden
,
Jan Holst
The Departments of Surgery and Experimental Research, Lund University, Malmö General Hospital, Malmö, Sweden
,
David Bergqvist
The Departments of Surgery and Experimental Research, Lund University, Malmö General Hospital, Malmö, Sweden
› Author Affiliations
Further Information

Publication History

Received: 09 October 1992

Accepted after revision 12 September 1993

Publication Date:
06 July 2018 (online)

Summary

An experimental model based on the combination of endothelial damage and flow reduction was used to induce jugular vein thrombosis in rabbits. The effect on thrombosis of a low molecular weight heparin (LMWH [Fragmin]), dextran 70, placebo and their combination was studied in a double-blind fashion with actual doses used in clinical thromboprophylaxis. Saline and polygeline were used as placebo in the control group. Four groups with 120 isolated vein segments in 60 animals were studied for presence of thrombus formation, occlusive thrombi and thrombus weights. Dextran reduced the thrombus weights (p = 0.048) and the formation of occlusive thrombi (p = 0.01), but not the formation of thrombi when compared with the placebo control group. Similarily, LMWH reduced the thrombus weights (p = 0.046), the formation of thrombi (p = 0.007) and occlusive thrombi (p = 0.0001). Compared with the LMWH group the group treated with the combination of LMWH and dextran was found to reduce the frequency of occlusive thrombi (p = 0.03) and numerically, but not significantly, further reduce the overall frequency of thrombosis (p = 0.18) and thrombus weights (p = 0.11). The results are consistent with an augmentation of the antithrombotic effect of LMWH by dextran 70. The need for further evaluation of the combined efficacy of LMWH and dextran is apparent from this study.

 
  • References

  • 1 Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Results of Meta-analysis. Ann Surg 1988; 208: 227-40
  • 2 Kakkar VV, Murray WGJ. Efficacy and safety of low molecular weight heparin (CY 216) in preventing postoperative venous thromboembolism: A cooperative study. Br J Surg 1985; 72: 786-91
  • 3 Peterson J, Zucker MB. The effect of adenosine monophosphate, arcaine and anti-inflammatory agents on thrombosis and platelet function in rabbits. ThrombDiath Haemorrh 1970; 23: 148-58
  • 4 Björck CG, Bergqvist D, Esquivel C, Nilsson B, Rudsvik Y. Effect of heparin, low molecular weight heparin and heparin analogue on experimental venous thrombosis in the rabbit. Acta Chir Scand 1984; 150: 629-33
  • 5 Stibbe J, Plas PM, Ong GL, Hoor F, Nauta J. Effects of the gelatin plasma substitutes; Haemaccel®, Plasmagel® and Plasmion® (Geloplasma®) on collagen-, ADP- and adrenalin induced aggregation of human platelets in vitro. Haemostasis 1981; 10: 276-88
  • 6 Esquivel CO, Bergqvist D, Björck CG, Nilsson B. Comparison between commercial heparin, low molecular weight heparin and pentosan polysulphate on haemostasis and platelets in vivo. Thromb Res 1982; 28: 389-99
  • 7 Holst J, Lindblad B, Mätzsch T, Bergqvist D. Effect on primary haemostasis of prophylactic regimes of low molecular weight heparin, unfractionated heparin, dextran and their combinations. An animal experimental study. Thromb Res 1992; 65: 651-6
  • 8 Bergqvist D. Effects of dextran. National board of health and welfare. Drug information committee Workshop; Uppsala Sweden: 1988. (; 2). 7-23
  • 9 Bloom WL, Harmer DS, Bryant MF, Brewer Jr SS. Coating of vascular surfaces and cells. A new concept in prevention of intravascular thrombosis. Proc Soc Exp Biol Med 1964; 115: 384-6
  • 10 Bygdeman S, Eliasson R. Effect of dextrans in vitro on the adenosine diphosphate induced adhesiveness of human blood platelgts. Thromb Diath Haemorrh 1966; 15: 436-41
  • 11 Åberg M, Hedner U, Bergentz SE. Effect of dextran on factor VIII and platelet function. Ann Surg 1979; 189: 243-7
  • 12 Aberg M, Bergentz SE. The effect of dextran on the platelet distribution and lysability of ex vivo thrombi in dogs. Eur Surg Res 1979; 11: 282-7
  • 13 Bloom WL, Fowler NO, Ward JA, Franch RH. Hemodilution and changes in hemostasis induced by dextran. An experiment in dogs with and without plasma volume expansion. J Surg Res 1963; 3: 152-8
  • 14 Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992; 79: 1-17
  • 15 Ah-See AK, Arfors KE, Bergqvist D, Tangen O. Effect of dextran on experimental venous thrombosis in rabbits. Thromb Diath Haemorrh 1974; 32: 284-91
  • 16 Bergqvist D. The influence of plasma volume expanders on initial haemostasis in the rabbit mesentery. Acta Anaesthesiol Scand 1985; 29: 607-9